Reynoso R, Morán MÁ, Méndez-Sánchez N

Language: Spanish
References: 14
Page: 15-17
PDF size: 52.84 Kb.

ABSTRACT

Cholangiocarcinoma is an infrequent tumor originating from the bile duct epithelium, either intrahepatic or extrahepatic. It is more frequently present in patients with bile duct chronic inflammatory conditions. Its more usual presentation is painless jaundice. Frequently this tumor is irresecable at the time of diagnosis, and only palliative management can be offered, either surgical or endoscopic. Endoscopic cholangiography is a good option for bile duct decompression in distal tumors, although it is of little use in those tumors that involve both hepatic ducts. Prognosis for patients with this tumor is poor, since it has a high mortality and morbidity rate on short term.

REFERENCES

1. Ahrendt S, Nakeeb A, Pitt H. Liver Tumors. Cholangiocarcinoma. Clinics in Liver Disease 5:1. 2001.

2. American Joint Committee on Cancer: Gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Fleming ID, Cooper JS, Henson DE (eds): AJCC Cancer Staging Manual, ed 5. Philadelphia, Lippincott-Raven, 1997: 103–119.

3. Villalobos JJ. Estudio prolectivo de 10 años de cáncer del aparato digestivo. Rev Gastroenterol Mex 1990; 55: 17-24.

4. Ahrendt SA, Pitt HA, Nakeeb A et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. Journal of Gastrointestinal Surgery 1999; 3: 357.

5. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer Statistics, 2000. CA Cancer J Clin 2000; 50: 7.

6. Chu KM, Lai EC, Al-Hadeedi S et al. Intrahepatic cholangiocarcinoma. World J Surg 1997; 21: 301.

7. Hultcrantz R, Olsson R, Danielsson A et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999; 30: 669.

8. Magnuson TH, Bender JS, Duncan MD et al. Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction. J Am Coll Surg 1999; 189: 63.

9. Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinomas T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 1996; 201: 347.

10. Ahrendt SA, Cameron JL, Pitt HA. Current management of patients with perihilar cholangiocarcinoma. In: Cameron JL (ed): Advances in Surgery, Vol. 30. St. Louis, Mosby, 1996: 427.

11. Lai EC, Chu KM, Lo CY et al. Choice of palliation for malignant hilar obstruction. Am J Surg 1992; 163: 208.

12. Nordback IH, Pitt HA, Coleman JA et al. Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery 1994; 115: 597.

13. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47: 354.

14. Kobayashi S, Asano T, Yamasaki M et al. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary malfunction. Surgery 1999; 126: 939.